Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sight Sciences, Inc.

4.21
-0.0200-0.47%
Post-market: 4.210.00000.00%16:04 EDT
Volume:62.79K
Turnover:264.41K
Market Cap:220.47M
PE:-4.39
High:4.23
Open:4.22
Low:4.09
Close:4.23
52wk High:7.05
52wk Low:2.03
Shares:52.37M
Float Shares:28.82M
Volume Ratio:0.60
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9597
EPS(LYR):-1.0274
ROE:-57.10%
ROA:-22.40%
PB:3.15
PE(LYR):-4.10

Loading ...

Sight Sciences Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
May 07

Artivion (AORT) Lags Q1 Earnings Estimates

Zacks
·
May 06

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

GlobeNewswire
·
Apr 25

Sight Sciences Announces the Release of its Sustainability Report

GlobeNewswire
·
Apr 24

Press Release: Sight Sciences Appoints Gary Burbach to its Board of Directors

Dow Jones
·
Apr 23

Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

GlobeNewswire
·
Apr 22

The Market Meltdown Is No Match for Our Quant System’s 5 Latest Picks

InvestorPlace
·
Apr 14

Needham Sticks to Its Hold Rating for Sight Sciences (SGHT)

TIPRANKS
·
Apr 09

Sight Sciences, Inc. (NASDAQ:SGHT) Looks Inexpensive But Perhaps Not Attractive Enough

Simply Wall St.
·
Mar 30

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

GlobeNewswire
·
Mar 26

Sight Sciences’ Earnings Call: Cautious Optimism Amid Challenges

TIPRANKS
·
Mar 07

Q4 2024 Sight Sciences Inc Earnings Call

Thomson Reuters StreetEvents
·
Mar 07

Sight Sciences Is Maintained at Neutral by Piper Sandler

Dow Jones
·
Mar 06

Sight Sciences price target lowered to $2.50 from $3 at Lake Street

TIPRANKS
·
Mar 06

Sight Sciences price target lowered to $4 from $5 at Stifel

TIPRANKS
·
Mar 06

Sight Sciences: Hold Rating Amid Revenue Challenges and Reimbursement Progress

TIPRANKS
·
Mar 06

Sight Sciences price target lowered to $3.50 from $5.50 at Piper Sandler

TIPRANKS
·
Mar 06

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Envista Holdings (NVST) and Sight Sciences (SGHT)

TIPRANKS
·
Mar 06

Sight Sciences Faces Headwinds in Glaucoma and Dry Eye Markets, Hold Rating Maintained

TIPRANKS
·
Mar 06

Sight Sciences Inc (SGHT) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Challenges

GuruFocus.com
·
Mar 06